Peptides for delivery of mucosal vaccines

Details Peptides for delivery of mucosal vaccines Peptides for delivery of mucosal vaccines

A - Human Necessities

61

K

A61K 39/295 (2006.01) A61K 39/116 (2006.01)

Patent

CA 2594911

The present invention is directed to a adjuvant peptide and uses to facilitate antigen absorption in the mucosa, particularly nasal tissue. Vaccine compositions for mucosal delivery include the adjuvant peptide and an antigen for inducing an immune response.

L'invention concerne un peptide adjuvant et des utilisations permettant de faciliter l'absorption d'antigènes dans les muqueuses, notamment le tissu nasal. L'invention concerne également des compositions de vaccin destinées à l'administration muqueuse et comprenant le peptide adjuvant et un antigène, de manière à induire une réponse immune.

Affiliated with

Also associated with

Rating

Peptides for delivery of mucosal vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides for delivery of mucosal vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for delivery of mucosal vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1569311